Jennifer Burstein's Insider Trades & SAST Disclosures

Jennifer Burstein's most recent trade in Stoke Therapeutics Inc was a trade of 7,639 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Stoke Therapeutics Inc
Jennifer C. Burstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 7,639 7,639 - - Director Stock Option (Right to Buy)
Stoke Therapeutics Inc
Jennifer C. Burstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2023 19,441 19,441 - - Director Stock Option (Right to Buy)
Stoke Therapeutics Inc
Jennifer C. Burstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2022 21,000 21,000 - - Director Stock Option (Right to Buy)
Stoke Therapeutics Inc
Jennifer C. Burstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2021 11,650 11,650 - - Director Stock Option (Right to Buy)
Stoke Therapeutics Inc
Jennifer Burstein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jun 2020 14,777 14,777 - - Director Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades